CASEY TAYLOR: Open Payments
NPI 1922603976 · CANDOR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,057 in 100 payments from 13 companies in 2025. Trend: 2023 $1,381 · 2024 $2,064 · 2025 $2,057
Food & beverage: $2,057
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $616 |
| AstraZeneca Pharmaceuticals LP | 18 | $379 |
| Exact Sciences Corporation | 11 | $241 |
| Novo Nordisk Inc | 8 | $177 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $148 |
| Lilly USA, LLC | 7 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $122 |
| Amgen Inc. | 4 | $82 |
| Verona Pharma, Inc. | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $42 |
Products named: VRAYLAR, AIRSUPRA, JARDIANCE, The Cologuard Plus Collection Kit, MOUNJARO, CAPLYTA, UBRELVY, FARXIGA.
Industry payments across NY — which companies pay providers there.
